Liquid formulation of efavirenz available for children in the uk on named patient basis
A named-patient programme is now available for a new liquid formulation of efavirenz, for use in paediatric HIV-care in children aged three years or older. The programme may also be extended if there is sufficient demand.
The liquid is a clear, strawberry-flavoured solution administered once-daily and may be taken with or without food. Participants will be dosed with efavirenz based on their body weight. Efavirenz has not been adequately studied in children weighing less than 13 kg or in children under three years of age and should not be given to children falling into these categories.
Currently, 100 mg and 50 mg capsules of efavirenz are available for paediatric use.
Contact DuPont Pharmaceuticals on 01438 842613.